Comments on: Risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis.
Hepatol Int
; 18(2): 702-703, 2024 Apr.
Article
in En
| MEDLINE
| ID: mdl-38429497
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hepatitis B, Chronic
/
Dyslipidemias
Limits:
Humans
Language:
En
Journal:
Hepatol Int
/
Hepatol. int. (Internet)
/
Hepatology international (Internet)
Year:
2024
Document type:
Article
Affiliation country:
Country of publication: